| Sivaram Rajan, MD | |
|
211 Essex St, Hackensack, NJ 07601-3231 | |
| (551) 999-6433 | |
| Not Available |
| Full Name | Sivaram Rajan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 211 Essex St, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073583746 | NPI | - | NPPES |
| 2018209 | Medicaid | MA | |
| 30204220 | Medicaid | NH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics tomorrow (Monday 2 June) Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says that these findings mean that women should be better informed on the limitations of such diagnostic tests.
Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large collaborative research project of medical centers in the USA and Canada.
Frequent hemodialysis improved left ventricular mass (heart size) and self-reported physical health compared to conventional hemodialysis for kidney failure, according to the Frequent Hemodialysis Network (FHN) Daily Trial funded by the National Institutes of Health and the Centers for Medicare & Medicaid Services.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
› Verified 7 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics tomorrow (Monday 2 June) Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says that these findings mean that women should be better informed on the limitations of such diagnostic tests.
Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large collaborative research project of medical centers in the USA and Canada.
Frequent hemodialysis improved left ventricular mass (heart size) and self-reported physical health compared to conventional hemodialysis for kidney failure, according to the Frequent Hemodialysis Network (FHN) Daily Trial funded by the National Institutes of Health and the Centers for Medicare & Medicaid Services.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
› Verified 7 days ago
| Entity Name | Rajan Orthopaedics And Sports Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508242355 PECOS PAC ID: 0446566020 Enrollment ID: O20150827000197 |
News Archive
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics tomorrow (Monday 2 June) Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says that these findings mean that women should be better informed on the limitations of such diagnostic tests.
Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large collaborative research project of medical centers in the USA and Canada.
Frequent hemodialysis improved left ventricular mass (heart size) and self-reported physical health compared to conventional hemodialysis for kidney failure, according to the Frequent Hemodialysis Network (FHN) Daily Trial funded by the National Institutes of Health and the Centers for Medicare & Medicaid Services.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sivaram Rajan, MD 1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 Ph: (908) 273-4300 | Sivaram Rajan, MD 211 Essex St, Hackensack, NJ 07601-3231 Ph: (551) 999-6433 |
News Archive
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics tomorrow (Monday 2 June) Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says that these findings mean that women should be better informed on the limitations of such diagnostic tests.
Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large collaborative research project of medical centers in the USA and Canada.
Frequent hemodialysis improved left ventricular mass (heart size) and self-reported physical health compared to conventional hemodialysis for kidney failure, according to the Frequent Hemodialysis Network (FHN) Daily Trial funded by the National Institutes of Health and the Centers for Medicare & Medicaid Services.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
› Verified 7 days ago
Dr. Oscar Vazquez, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Prospect Ave, Hackensack, NJ 07601 Phone: 201-343-2277 Fax: 201-343-7410 | |
Pavel Vladimirovich Yufit, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 214 State St Ste 101, Hackensack, NJ 07601 Phone: 201-342-7662 Fax: 201-342-7662 | |
Dr. John Thomas Andronaco, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-845-9300 Fax: 201-845-9301 | |
Dr. James W Cahill, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 87 Summit Ave, Hackensack, NJ 07601 Phone: 201-489-0022 Fax: 201-489-6991 | |
Dr. Richard Dongil Rhim, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Prospect Ave, Hackensack, NJ 07601 Phone: 201-343-2277 Fax: 201-343-7410 | |
Stephen Rossman, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 360 Essex St Ste 203, Hackensack, NJ 07601 Phone: 551-996-8867 Fax: 551-996-8873 |